MGLIX
Price
$16.46
Change
-$0.04 (-0.24%)
Updated
Dec 17 closing price
RRGAX
Price
$7.20
Change
-$0.02 (-0.28%)
Updated
Dec 17 closing price
Ad is loading...

MGLIX vs RRGAX

Header iconMGLIX vs RRGAX Comparison
Open Charts MGLIX vs RRGAXBanner chart's image
MFS Global Real Estate I
Price$16.46
Change-$0.04 (-0.24%)
VolumeN/A
CapitalizationN/A
DWS RREEF Global Real Estate Secc A
Price$7.20
Change-$0.02 (-0.28%)
VolumeN/A
CapitalizationN/A
MGLIX vs RRGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLIX vs. RRGAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLIX is a Sell and RRGAX is a Hold.

FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.32B vs. RRGAX (156M). MGLIX pays higher dividends than RRGAX: MGLIX (1.87) vs RRGAX (1.09). MGLIX was incepted earlier than RRGAX: MGLIX (16 years) vs RRGAX (18 years). RRGAX is a more actively managed with annual turnover of: 82.00 vs. MGLIX (30.00). MGLIX has a lower initial minimum investment than RRGAX: MGLIX (0) vs RRGAX (1000). RRGAX annual gain was more profitable for investors over the last year : 7.37 vs. MGLIX (1.37). MGLIX return over 5 years is better than : 3.66 vs. RRGAX (-5.91).
MGLIXRRGAXMGLIX / RRGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years18 years-
Gain YTD-0.3085.688-5%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.32B156M1,485%
Annual Yield % from dividends1.871.09171%
Returns for 1 year1.377.3719%
Returns for 3 years-19.65-14.93132%
Returns for 5 years3.66-5.91-62%
Returns for 10 years30.9414.89208%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CABA2.750.04
+1.48%
Cabaletta Bio
OBE5.14N/A
N/A
Obsidian Energy Ltd
NI36.21-0.13
-0.36%
NiSource
RVLV36.51-1.60
-4.20%
Revolve Group
SYRS0.21-0.01
-4.91%
Syros Pharmaceuticals